Molecular imaging leader backs research aimed at tangible clinical benefits

October 13, 2008 Molecular imaging leader backs research aimed at tangible clinical benefits Paula Gould Dr. Markus Schwaiger, a leader in the drive toward molecular imaging advancements in Europe, has thrown his support to research designed to foster tangible clinical benefits in the diagnosis and treatment of neurodegeneration, coronary artery disease, and cancer. Molecular imaging research is benefiting enormously from the energy of a relatively young, enthusiastic workforce, Schwaiger said in September during the inaugural lecture at the World Molecular Imaging Congress in Nice, France.

See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC